7498 Results (Page 292 of 300)
Pharmaceuticals Markets Research Reports
Germany Actinic Keratosis Therapeutic Market Analysis
The Germany Actinic Keratosis Therapeutic Market is expected to grow at a CAGR of 3.10%, rising from $249 Mn in the year 2022 reaching $318 Mn by the year 2030. The rising incidence of actinic keratosis, improvements in treatment options, rising public awareness and screening programs, encouraging government initiatives, technological advancements, an aging population, market competition, and patient preferences are the factors driving the Germany Actinic Keratosis Therapeutic Market. The key players in the Germany Actinic Keratosis Therapeutic Market include Bayer, Galderma, Pierre Fabre, Chemiplastics, Oncopharma, Aclaris Therapeutics, Varens, Photocure, Meda Pharma etc.
Egypt Constipation Therapeutics Market Analysis
Egypt Constipation Therapeutics Market was valued at $51 Mn in 2022 and is estimated to reach $94 Mn in 2030, exhibiting a CAGR of 8% during the forecast period. The global growth of the constipation therapeutics market is driven by factors such as aging, sedentary lifestyles, and unhealthy dietary habits. The increasing elderly population, susceptible to chronic conditions, notably contributes to this expansion. Major players in this sector comprise Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Merck & Co., Novartis, and Pfizer.
South Africa Lipid Disorder Therapeutics Market Analysis
South Africa Lipid Disorder Therapeutics Market was valued at $252.5 Mn in 2023 and is predicted to grow at a CAGR of 13.63% from 2023 to 2030, to $617.6 Mn by 2030. South Africa Lipid Disorder Therapeutics Market is growing due to Advancements in Therapeutics, Increasing Healthcare Expenditure, and the Rising Prevalence of Cardiovascular Diseases (CVDs). The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd., Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
France Constipation Therapeutics Market Analysis
France Constipation Therapeutics Market was valued at $501 Mn in 2022 and is estimated to reach $768 Mn in 2030, exhibiting a CAGR of 5.5% during the forecast period. The constipation therapeutics market is experiencing growth driven by rising global rates of constipation associated with factors like aging, sedentary lifestyles, and poor dietary habits, as well as the expanding elderly population, which is particularly prone to chronic conditions. Notable participants in this industry include AbbVie, Almirall, Boehringer Ingelheim, Ferring Pharmaceuticals, Ipsen Pharma, Johnson & Johnson, Norgine Pharmaceuticals, Pierre Fabre Médicament, Recordati and Sanofi.
India Lipid Disorder Therapeutics Market Analysis
The India Lipid Disorder Therapeutics Market was valued at $151.5 Mn in 2023 and is predicted to grow at a CAGR of 12.88% from 2023 to 2030, to $353.8 Mn by 2030. India Lipid Disorder Therapeutics Market is growing due to the Prevalence of cardiovascular diseases, Consumer preference for over-the-counter (OTC) drugs, Advancements in Therapeutics, and Growing Healthcare Expenditure and Infrastructure. The industry is primarily dominated by players such as Sun Pharmaceutical Industries Ltd., Cipla, Lupin, Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie, Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Japan Castrate Resistant Prostate Cancer Therapeutics Market Analysis
Japan Castrate Resistant Prostate Cancer Therapeutics Market valued at $634 Mn in 2022, projected to reach $1139 Mn by 2030 with a 7.6% CAGR. The key driver of the market in Japan is the significant surge in the aging population, particularly those at higher risk of age-related cancers, coupled with increased diagnostics, screening, and a growing awareness of the disease and treatment options. The Japan Castrate Resistant Prostate Cancer Therapeutics Market encompasses various players across different segments, including Pfizer, Johnson & Johnson, Sanofi, Bayer, Astellas, AbbVie, Eisai, Novartis, AstraZeneca, Bristol-Myers Squibb, etc, among various others.
Germany Constipation Therapeutics Market Analysis
Germany Constipation Therapeutics Market was valued at $666 Mn in 2022 and is estimated to reach $962 Mn in 2030, exhibiting a CAGR of 4.7% during the forecast period. The constipation therapeutics market is experiencing growth driven by rising global rates of constipation associated with factors like aging, sedentary lifestyles, and poor dietary habits, as well as the expanding elderly population, which is particularly prone to chronic conditions. Notable participants in this industry include AbbVie, Almirall, Boehringer Ingelheim, Ferring Pharmaceuticals, Ipsen Pharma, Johnson & Johnson, Norgine Pharmaceuticals, Pierre Fabre Médicament, Recordati, and Sanofi.
Kenya Actinic Keratosis Therapeutic Market Analysis
Kenya Actinic Keratosis Therapeutic Market is expected to expand at a CAGR of 6% from $5 Mn in 2022 to $8 Mn by 2030. The market is expected to grow as a result of rising prevalence combined with specific environmental variables, a shifting economic landscape, rising disposable incomes, and more access to healthcare services in Kenya. International and local players Galderma, Bayer, Novartis, Mediheal Pharmaceuticals, Mifa, Kepharth etc, contribute to the therapeutic management of Actinic Keratosis
China Castrate Resistant Prostate Cancer Therapeutics Market Analysis
China Castrate Resistant Prostate Cancer Therapeutics Market valued at $28 Mn in 2022, projected to reach $450 Mn by 2030 with a 6.10% CAGR. The key drivers of this market are the rapidly aging population in China, with an increasing risk of prostate cancer, coupled with the evolving healthcare system reforms, increased government investment, and accessibility of innovative CRPC therapies by multinational pharmaceutical companies. The China Castrate Resistant Prostate Cancer Therapeutics Market encompasses various players across different segments, including Pfizer, Johnson & Johnson, Roche, Bayer, AstraZeneca, Sanofi, BeiGene, Innovent Biopharmaceuticals, Shanghai Junshi Biosciences, Henlius Biotech, etc, among various others.
Indonesia Constipation Therapeutics Market Analysis
Indonesia Constipation Therapeutics Market was valued at $109 Mn in 2022 and is estimated to reach $181 Mn in 2030, exhibiting a CAGR of 6.5% during the forecast period. The constipation therapeutics market is experiencing growth driven by the rising prevalence of constipation worldwide, attributed to factors like aging, sedentary lifestyles, and unhealthy dietary habits, with the expanding elderly population, more prone to chronic conditions, further contributing to this market expansion. Notable participants in this industry include Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Roche, and Sanofi.
Japan Constipation Therapeutics Market Analysis
Japan Constipation Therapeutics Market was valued at $1131 Mn in 2022 and is estimated to reach $1944 Mn in 2030, exhibiting a CAGR of 7% during the forecast period. The constipation therapeutics market is experiencing growth driven by the rising prevalence of constipation worldwide, attributed to factors like aging, sedentary lifestyles, and unhealthy dietary habits, with the expanding elderly population, more prone to chronic conditions, further contributing to this market expansion. Notable participants in this industry include Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Roche, and Sanofi.
Spain Actinic Keratosis Therapeutic Market Analysis
The Spain Actinic Keratosis Therapeutics Market was valued at $131 Mn in 2023 and is expected to reach $178 Mn by 2030, growing at a CAGR of 3.9%. The Spain Actinic Keratosis Therapeutics Market presents a promising outlook with rising prevalence, increasing public awareness campaigns to educate individuals about risks and the importance of early detection, increasing focus on early intervention, and development of novel treatment options. Major pharmaceutical companies like Bayer, Galderma, Pierre Fabre, Chemiplastics, Oncopharma, etc hold significant market shares
Canada Brain Cancer Therapeutics Market Analysis
Canada Brain Cancer Therapeutics Market valued at $184 Mn in 2022, projected to reach $1412 Mn by 2030 with a 10.6% CAGR. A significant rise in the occurrence of brain cancer, specifically glioblastoma multiforme, is expected to drive the demand for treatments in the brain cancer therapeutics market. The leading pharmaceutical companies currently operating in the industry are Roche, Novartis, Merck, Pfizer, BMS, Bayer, Celgene, AbbVie, Teva Pharmaceuticals, and Spectrum Pharmaceuticals.
Kenya Constipation Therapeutics Market Analysis
Kenya Constipation Therapeutics Market was valued at $13 Mn in 2022 and is estimated to reach $23 Mn in 2030, exhibiting a CAGR of 7.6% during the forecast period. The constipation therapeutics market is experiencing worldwide expansion due to factors like aging, sedentary lifestyles, and poor dietary habits. The growing elderly demographic, prone to chronic conditions, plays a significant role in driving this growth. Key players in this industry include Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Merck & Co., Novartis, and Pfizer.
Mexico Actinic Keratosis Therapeutic Market Analysis
Mexico Actinic Keratosis Therapeutic Market is expected to expand at a CAGR of 5.15% from $102 Mn in 2022 to $152 Mn by 2030. Rising prevalence paired with certain environmental factors, changing economic landscape, disposable incomes and increasing access to healthcare services in Mexico are assumed to contribute to the market's expansion. International and local players LEO Pharma, Bausch Health, Almirall, 3M, Cipher Pharmaceuticals, and Lumenis etc contribute with cryotherapy and light therapy devices used for the therapeutic management of Actinic Keratosis
Germany Brain Cancer Therapeutics Market
Germany Brain Cancer Therapeutics Market valued at $84 Mn in 2022, projected to reach $165 Mn by 2030 with a 9.8% CAGR. The expected rise in incidents of brain cancer, specifically glioblastoma multiforme, is projected to significantly drive the demand for brain cancer therapeutics, influencing the overall market scenario. Leading pharmaceutical companies currently working in the market are Roche, Merck & Co., Bristol Myers Squibb, Novartis, Pfizer, AstraZeneca, Eli Lilly, Sanofi, Takeda Pharmaceutical, and AbbVie.
Malaysia Constipation Therapeutics Market Analysis
Malaysia Constipation Therapeutics Market was valued at $29 Mn in 2022 and is estimated to reach $49 Mn in 2030, exhibiting a CAGR of 6.7% during the forecast period. The constipation therapeutics market is growing globally, propelled by factors like aging, sedentary lifestyles, and unhealthy dietary patterns, with the expanding elderly population, more prone to chronic conditions, contributing significantly to this expansion. Key players in this industry include Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Roche, and Sanofi.
Canada Brugada Syndrome Market Analysis
The Canada Brugada Syndrome Market was valued at $96 Mn in 2023 and is predicted to grow at a CAGR of 7.8% from 2023 to 2030, to $162.4 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increasing awareness and diagnosis, and advancements in genetic testing. The prominent players of the Canada Brugada Syndrome Market are GeneDX, Abbott, PGxHealth LLC, Medtronic, and GE Healthcare, among others.
Philippines Actinic Keratosis Therapeutic Market Analysis
According to estimates, the Philippines Actinic Keratosis Therapeutic Market is expected to reach around $23 Mn by 2030, up from $15 Mn in 2022, growing at a compound annual growth rate of 5.4% over the forecast period. The Philippines Actinic Keratosis Therapeutic Market is set to expand with enhanced treatment options, telemedicine advancements, government initiatives in remote healthcare, and a growing prevalence due to changing lifestyles and aging population, all contributing to heightened market demand. DUSA Pharmaceuticals, Novartis, Perrigo, LEO Pharma, Bausch Health, Taro Pharmaceutical etc are the key players in the Philippines Actinic Keratosis Therapeutic Market
China Brain Cancer Therapeutics Market
China Brain Cancer Therapeutics Market valued at $185 Mn in 2022, projected to reach $461 Mn by 2030 with a 12.1% CAGR. The anticipated increase in cases of brain cancer, particularly glioblastoma multiforme, is expected to markedly boost the need for brain cancer therapeutics, shaping the overall market landscape significantly. The top leading pharmaceutical companies currently operating in the market are Innovent, Hutchison MediPharmaceuticals, China Resources Pharmaceutical Group (CRPG), BeiGene, Hansoh Pharmaceutical Group Co., Zhejiang Hisun Pharmaceutical Co., Yishuntai Pharmaceuticals Group Co., Jiangsu Hengrui Medicine Co., Shanghai Junsun Science & Technology Co. and Guangzhou Institute of Biopharmaceutical Technology (GIBT).
Mexico Constipation Therapeutics Market Analysis
Mexico Constipation Therapeutics Market was valued at $273 Mn in 2022 and is estimated to reach $460 Mn in 2030, exhibiting a CAGR of 6.75% during the forecast period. The constipation therapeutics market is experiencing growth driven by rising global rates of constipation associated with factors like aging, sedentary lifestyles, and poor dietary habits, as well as the expanding elderly population, which is particularly prone to chronic conditions. Notable participants in this industry include AbbVie, Allergan, Boehringer Ingelheim, EMS, Farmoquímica, Grünenthal, Johnson & Johnson, Norgine, Pfizer, and Sanofi.
Canada Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Canada Clinical Nutrition for Chronic Kidney Diseases Market was valued at $125.60 Mn in 2023 and is predicted to grow at a CAGR of 6.03% from 2023 to 2030, to $189.20 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, growing awareness and diagnosis, advancements in medical research, and the aging population. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
US Brugada Syndrome Market Analysis
The US Brugada Syndrome Market was valued at $504 Mn in 2023 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $747.9 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increasing awareness and diagnosis, and advancements in genetic testing. The prominent players of the US Brugada Syndrome Market are Johnson & Johnson, Eli Lilly & Co, AbbVie, Merck & Co Inc, Pfizer, Bristol-Myers Squibb, Amgen Inc, Gilead Sciences, Medtronic, and AstraZeneca, among others.
Saudi Arabia Actinic Keratosis Therapeutic Market Analysis
The Saudi Arabia Actinic Keratosis Therapeutic Market is expected to witness substantial growth, with an estimated increase from $116 Mn in 2022 to $190 Mn by 2030 and a forecasted CAGR projected to be 6.4%. This expected growth is attributed to the intersection of certain factors such as the sun-exposed demographics in Saudi Arabia, increased public awareness of Actinic Keratosis and the ways of treating it, and a growing array of treatment options, including advanced technological solutions and minimally invasive procedures. Key players in the Saudi Arabia Actinic Keratosis Therapeutics Market include Bayer, Galderma, LEO Pharma, Sun Pharmaceuticals, Syneron Candela, Lumenis, Zimmer Biomet, among others
Brazil Brain Cancer Therapeutics Market Analysis
Brazil Brain Cancer Therapeutics Market valued at $58 Mn in 2022, projected to reach $138 Mn by 2030 with a 11.6% CAGR. The market for brain cancer therapeutics is expected to be driven by the anticipated rise in the incidence of brain cancer, especially glioblastoma multiforme, which would raise the demand for therapeutics. Among the prominent players in the pharmaceutical sector are Pfizer, AstraZeneca, Merck & Co., Siemens, Carestream Health, Eisai Co., Genentech, Bristol-Myers Squibb, Eli Lilly, and Sanofi.